The technology currently has CE mark outside the U.S. and is targeting Premarket Approval submission to the FDA in 2017.
About Seno Medical Instruments, Inc.
Ad Statistics
Times Displayed: 23457
Times Visited: 520 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno Medical's Imagio breast imaging system fuses opto-acoustic technology with ultrasound (OA/US) to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno Medical believes that the Imagio™ OA/US breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents. To learn more about Seno Medical's OA/US imaging technology and applications, visit www.SenoMedical.com.
SOURCE Seno Medical Instruments, Inc.
Back to HCB News
